Compare iShares Russell 2000 ETF (IWM) vs Kymera Therapeutics Inc. Common Stock (KYMR) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
iShares Russell 2000 ETF vs Kymera Therapeutics Inc. Common Stock — how do they compare? iShares Russell 2000 ETF trades at $272.21 (market cap $75.59B), while Kymera Therapeutics Inc. Common Stock trades at $105.11 (market cap $8.88B). The key difference: iShares Russell 2000 ETF is far larger — about 8.5× Kymera Therapeutics Inc. Common Stock's market cap, and Kymera Therapeutics Inc. Common Stock is trading nearer its 52-week high, iShares Russell 2000 ETF nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold iShares Russell 2000 ETF for 83 Days and Kymera Therapeutics Inc. Common Stock for 0 Days on average.
| IWM | KYMR | |
|---|---|---|
Market Cap | $75.59B | $8.88B |
Volume | 37,947,395 | 1,028,790 |
52-Week High | $305.06 | $127.31 |
52-Week Low | $229.13 | $55.80 |
Typical Hold Time | 83 Days | 0 Days |
Sector | — | Health |
Enterprise Value | — | $8.27B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
IWM trades at $276.71, down 0.42% amid bearish technical signals with 15 sell indicators versus 2 buy signals. The ETF faces headwinds from Federal Reserve rate hikes and underperformance relative to the S&P 500 over the past decade. Recent news highlights concerns about small-cap risk premiums and competition from more selective small-cap funds.
The outlook remains challenged by interest rate sensitivity and broader market rotation away from small caps. While offering diversification from large-cap tech concentration, IWM's inclusion of unprofitable companies presents fundamental risks. Near-term performance depends on Fed policy clarity and small-cap earnings resilience.
No Aura AI signal available yet.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About iShares Russell 2000 ETF
The ETF is designed to track the performance of the securities and the stocks in the Russell 2000 Index. To maintain the composition and weightings, the advisor adjusts the ETF from time to time to conform to periodic changes in the index target.
Read more on IWM →About Kymera Therapeutics Inc. Common Stock
Kymera Therapeutics, Inc. is a biopharmaceutical company developing small-molecule medicines based on targeted protein degradation, using its Pegasus platform to direct the body's natural protein-disposal system against disease-causing proteins.
Read more on KYMR →
